2020
DOI: 10.1016/j.psyneuen.2020.104657
|View full text |Cite
|
Sign up to set email alerts
|

Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 58 publications
1
3
0
Order By: Relevance
“…Interestingly, the included studies were consistent in showing declines in cortisol over the course of CBT for generalised anxiety disorder [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 ]. The only study published since the systematic review [ 31 ] investigated social anxiety disorder and confirmed an earlier null-finding regarding changes of cortisol during CBT [ 45 ].…”
Section: Cortisolsupporting
confidence: 55%
See 2 more Smart Citations
“…Interestingly, the included studies were consistent in showing declines in cortisol over the course of CBT for generalised anxiety disorder [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 ]. The only study published since the systematic review [ 31 ] investigated social anxiety disorder and confirmed an earlier null-finding regarding changes of cortisol during CBT [ 45 ].…”
Section: Cortisolsupporting
confidence: 55%
“…In contrast, the systematic review revealed consistent evidence for higher cortisol levels during the initial exposure sessions to predict better therapy outcomes [ 27 ]. One study in social anxiety disorder, which was published since the systematic review, reported a somewhat counterintuitive finding, namely that higher cortisol averaged across all exposure sessions predicted reduced improvement in fear [ 31 ]. Complementing the line of research on endogenous cortisol, a study in panic disorder and agoraphobia revealed that exposure sessions scheduled at later times during the day, when cortisol is low, were linked with fewer treatment gains than were sessions scheduled at earlier times during the day, when cortisol is high [ 32 ].…”
Section: Cortisolmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, it is perhaps unsurprising that numerous augmentations to exposure therapy have been examined. Although a complete review of augmentations for exposure therapy is beyond the scope of this paper, some enhancements examined to date include drug augmentations such as d-Cycloserine, which is thought to enhance memory consolidation [ 21 ], as well as scopolamine [ 22 ] and caffeine [ 23 ]. Additionally, several non-pharmacological augmentations have been explored, including virtual reality [ 10 ], aerobic exercise [ 24 ], attention training [ 25 ], power posing [ 26 ], and strategies informed by inhibitory learning/retrieval principles [ 11 , 17 ].…”
Section: Introductionmentioning
confidence: 99%